{"id":"https://openalex.org/W7066772887","doi":null,"title":"The Impact of Exercise on the Vulnerability of Dopamine Neurons to Cell Death in Animal Models of Parkinson's Disease","display_name":"The Impact of Exercise on the Vulnerability of Dopamine Neurons to Cell Death in Animal Models of Parkinson's Disease","publication_year":2004,"publication_date":"2004-07-01","ids":{"openalex":"https://openalex.org/W7066772887"},"language":"en","primary_location":{"id":"pmh:ADA425957","doi":null,"is_oa":false,"landing_page_url":"http://oai.dtic.mil/oai/oai?&amp;verb=getRecord&amp;metadataPrefix=html&amp;identifier=ADA425957","pdf_url":null,"source":{"id":"https://openalex.org/S4406923043","display_name":"Defense Technical Information Center (DTIC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DTIC","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010005592","display_name":"Michael Sigmond","orcid":"https://orcid.org/0000-0003-2191-9756","observed_orcids":["https://orcid.org/0000-0003-2191-9756"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sigmond, Michael J.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5010005592"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.53516535,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9380000233650208},{"id":"https://openalex.org/keywords/exercise","display_name":"physical activity","score":0.8769999742507935},{"id":"https://openalex.org/keywords/dopaminergic-neurons","display_name":"dopaminergic neurons","score":0.9710000157356262},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7250000238418579},{"id":"https://openalex.org/keywords/6-hydroxydopamine","display_name":"6-hydroxydopamine","score":0.9879999756813049},{"id":"https://openalex.org/keywords/casting","display_name":"casting","score":0.6449999809265137},{"id":"https://openalex.org/keywords/treadmill-running","display_name":"treadmill running","score":0.9869999885559082},{"id":"https://openalex.org/keywords/exercise-duration","display_name":"exercise duration","score":0.5350000262260437},{"id":"https://openalex.org/keywords/animal-models","display_name":"animal models","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.631600022315979},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6279000043869019},{"id":"https://openalex.org/C95713431","wikidata":"https://www.wikidata.org/wiki/Q631425","display_name":"Vulnerability (computing)","level":2,"score":0.6079999804496765},{"id":"https://openalex.org/C2780358027","wikidata":"https://www.wikidata.org/wiki/Q407752","display_name":"Neurotoxin","level":2,"score":0.6049000024795532},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5896000266075134},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5101000070571899},{"id":"https://openalex.org/C2778794669","wikidata":"https://www.wikidata.org/wiki/Q43054","display_name":"Neuron","level":2,"score":0.4316999912261963},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.43050000071525574},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.4101000130176544},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4099000096321106},{"id":"https://openalex.org/C181588539","wikidata":"https://www.wikidata.org/wiki/Q219067","display_name":"Physical exercise","level":2,"score":0.36489999294281006},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3578000068664551},{"id":"https://openalex.org/C2781464450","wikidata":"https://www.wikidata.org/wiki/Q839144","display_name":"Treadmill","level":2,"score":0.34380000829696655},{"id":"https://openalex.org/C2780369685","wikidata":"https://www.wikidata.org/wiki/Q5058184","display_name":"Cell damage","level":2,"score":0.287200003862381},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28459998965263367},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.2720000147819519},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2671000063419342},{"id":"https://openalex.org/C2778117688","wikidata":"https://www.wikidata.org/wiki/Q264024","display_name":"Animal model","level":2,"score":0.26669999957084656},{"id":"https://openalex.org/C2780130745","wikidata":"https://www.wikidata.org/wiki/Q1650750","display_name":"Neuropathology","level":3,"score":0.26440000534057617},{"id":"https://openalex.org/C2776752467","wikidata":"https://www.wikidata.org/wiki/Q1133903","display_name":"Motor neuron","level":3,"score":0.2515999972820282}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:ADA425957","doi":null,"is_oa":false,"landing_page_url":"http://oai.dtic.mil/oai/oai?&amp;verb=getRecord&amp;metadataPrefix=html&amp;identifier=ADA425957","pdf_url":null,"source":{"id":"https://openalex.org/S4406923043","display_name":"Defense Technical Information Center (DTIC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DTIC","raw_type":"Text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W202064371","https://openalex.org/W2164459320","https://openalex.org/W2987042935","https://openalex.org/W3055977664","https://openalex.org/W1970536603","https://openalex.org/W2014078610","https://openalex.org/W2991889558","https://openalex.org/W2665730350","https://openalex.org/W2742475176","https://openalex.org/W180579285"],"abstract_inverted_index":{"Parkinson's":[0],"disease":[1],"(PD)":[2],"results":[3,131],"in":[4,34,85,132],"part":[5],"from":[6,94],"the":[7,18,47,54,59,70,76,95,109,120,147,176,186],"loss":[8],"of":[9,20,39,58,78,97,114,129,138,165,172,192],"dopamine":[10],"(DA)":[11],"neurons.":[12],"We":[13,141],"hypothesize":[14],"that":[15],"exercise":[16,173,179],"reduces":[17],"vulnerability":[19],"DA":[21,82,98],"neurons":[22],"to":[23,30,62,92,125,150,154,174],"neurotoxin":[24],"exposure":[25,194],"and":[26,56,111,167,181,195],"have":[27,68,142],"outlined":[28],"experiments":[29],"test":[31],"this":[32],"hypothesis":[33],"rats":[35],"treated":[36],"with":[37,43,116,159],"one":[38],"several":[40],"neurotoxins,":[41],"beginning":[42],"6-hydroxydopamine":[44],"(6-OHDA).":[45],"Over":[46],"past":[48],"year,":[49],"we":[50,67],"established":[51],"a":[52],"staff,":[53],"training,":[55],"most":[57],"methodology":[60],"needed":[61],"perform":[63],"these":[64],"studies.":[65],"Subsequently,":[66],"observed":[69],"following:":[71],"(1)":[72],"Casting":[73],"protects":[74],"against":[75,108,135,156],"effects":[77,113],"6-OHDA":[79,115,130,139,157],"administered":[80],"along":[81],"axons":[83],"or":[84,105],"terminal":[86],"fields.":[87],"(2)":[88],"This":[89],"protection":[90,107,134,182],"appears":[91],"result":[93],"blockade":[96],"neuron":[99],"degeneration.":[100],"(3)":[101],"There":[102],"is":[103],"little":[104],"no":[106],"neuropathological":[110],"behavioral":[112],"treadmill":[117,160],"running":[118],"using":[119],"paradigms":[121],"examined.":[122],"(4)":[123],"Exposure":[124],"very":[126],"low":[127],"levels":[128,137],"significant":[133],"higher":[136],"exposure.":[140],"three":[143],"primary":[144],"objectives":[145],"for":[146],"coming":[148],"year:":[149],"complete":[151],"our":[152],"attempts":[153],"protect":[155],"toxicity":[158],"running,":[161],"explore":[162],"other":[163],"forms":[164],"exercise,":[166,190],"use":[168],"an":[169],"effective":[170],"form":[171],"examine":[175],"relation":[177,188],"between":[178,189],"duration":[180],"as":[183,185],"well":[184],"temporal":[187],"time":[191],"toxin":[193],"protection.":[196]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-10T00:00:00"}
